Efficacity of a Standardized Hypnotic Message on Pain Experienced During the Application of a Qutenza (Capsaicin) 8% Patch in Patients With Peripheral Neuropathic Pain
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain; Pain
- Focus Therapeutic Use
- Acronyms ENHYZA
- 25 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 25 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Feb 2018.
- 05 Dec 2016 Status changed from not yet recruiting to recruiting.